MF59

MF59 has been studied in 3 papers since 2017: none in people yet, 1 in animals, 2 reviews; 1 in the past year. The research so far is in animals. The newest paper, Nov 14, 2026: “Immunosenescence and vaccine adjuvants in older adults: from immune decline to signal reconstitution strategies”.

Intervention

3 papers study it1 findingUpdated

1 new paper in 30 daysSee all 3 papers on MF59

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: European Commission and 1 more
  • Animals1

What did studies of MF59 find?

1

Studies of MF59 measured one outcome, inflammation.

Inflammation

upin mice1

1 study
  1. MF59 induces inflammation in mice.

    “the addition of MF59 induced IL-5, granulocyte colony-stimulating factor (G-CSF), Keratinocyte Chemotractant (KC) and monocyte chemoattractant protein 1 (MCP1) in all ages of animals”

    Animals

    Inflammatory responses to influenza vaccination at the extremes of age

    Immunology

More on Inflammation

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 11 paper in 12 months